Frontlight ResearchEarly access
CompletedNo phase
Evolution of Sexual Life Quality of Women With POI Before and After Introduction of Hormone Replacement Therapy
Key facts
- Who runs it
- University Hospital, Bordeaux
- Where
- France2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 72 people enrolled
- Started
- 17 Jul 2023
- Ended
- 3 Apr 2026
- Type of study
- Interventional
- Treatments tested
- questionnaire
- Record updated
- 29 June 2026
Who can take part
- Age
- 18 years to 40 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- positive diagnosis of POI (amenorrhea > 4 months or spaniomenorrhea > 4 months and FSH > 25 IU/L checked twice, more than 4 weeks apart)
- absence of hormonal treatment,
- patient's oral consent,
- affiliated or beneficiary of health insurance
Who cannot take part
- contraindication to hormonal treatment (history of hormone-dependent cancer, history of ischemic arterial stroke),
- inability of the patient to understand the nature or risks or significance and implications of the clinical investigation,
- patient under legal protection
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to evaluate the evolution of quality of sex life of women with POI after introduction hormone replacement therapy through the FSFI scale
The group in the trial
- QuestionnairesTreatment being tested
Female Sexual Function Index (FSFI) and WHO Quality of Life-BREF (WHOQOL-BREF) questionnaires at baseline and at 6 months after starting hormone replacement therapy.
Treatment: questionnaire
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 29 June 2026